Antiphospholipid antibodies (aPL) 
Introduction

Antiphospholipid syndrome (APS) represents arterial or venous thrombosis associated with the presence of antiphospholipid antibodies (aPL). While APS is commonly associated with autoimmune disorders, transient aPL are often produced in response to viral infections (1). Human parvovirus B19 causes various clinical symptoms mimicking autoimmune disorders, including transient APS with venous thrombosis (2-6). Cytomegalovirus (CMV) also causes venous thrombosis in immunocompetent as well as immunosuppressed patients (7-13). We report a case of transient APS with multiple venous thrombosis after acute viral infection. Serological studies showed both possibilities of parvovirus B 19 and CMV infection.
Case Report
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right S 10 , right pulmonary arterial and superior mesentric venous thromboses (Fig. 1 (7) (8) (9) (10) (11) (12) (13) .
In the present case, both parvovirus B19 and CMV antibodies IgM were elevated. We suppose that this was due to either cross-reaction or coinfection. Cross-reaction has been reported between the commercial parvovirus B19 and CMV antibodies IgM: 20% of CMV IgM positive serum was positive for parvovirus B19 IgM; 8% of parvovirus B19 IgM positive serum was positve for CMV IgM (14). Both viruses cause mononucleosis-like illnesses and the transient presence of various autoantibodies (2, 3, 4, 11). The clinical course, including the transient presence of various autoantibodies, could not determine the pathogenic virus in this case. In parvovirus B19 infection, aPL have been thought to be associated with thromboembolic events. In all three reported cases including the present case, thromboembolic events were accompanied with the transient presence of aPL (5, 6). Landenberg et al reported that 58% of IgG aPL-positive children and 83% of those adults with rheumatic diseases showed acute or persistent infection of parvovirus B19.
Based on these data, they concluded that parvovirus B19 was associated with the induction of aPL (15) .
Molecular mimicry has been proposed as the main mechanism for production of aPL in parvovirus B19 infection (4) (5) (6) (19) . However, in only 4 of 21 reported cases, aPL were positive (7) (8) (9) (10) (11) (12) (13) (8, 9, 13) .
16). Landenberg et al reported that the phospholipase-A2-like activity is observed in the VP1-unique region of parvovirus B19 particle (15). This enzyme activity may lead to the generation of unnatural complexes with cellular proteins or unusual cleavage products from cellular phospholipids compounds that may induce aPL (15). In addition, the parvovirus B19 NS1 protein is also known to induce autoimmune phenomena by transactivation of the expression of TNF-α and IL-6 (17, 18). In CMV infection, several mechanisms responsible for thromboembolic events have been proposed. Gharavi et al showed that aPL, that were induced in mice by immunization with a CMV-derived peptide, caused thrombosis and activation of endothelial cells in vivo
The reason why aPL following viral infection are not pathogenic in most cases remains to be determined. One reason postulated is that most viral infections produce β2-GPI-independent aPL (1, 6) . β2-GPI is a single chain normal plasma protein that binds anionic phospholipids as a cofactor and is considered to be a regulator of coagulation. Pathogenic aPL are thought to require β2-GPI for binding to phospholipids (20) . Gharavi 
